{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:03:15Z","timestamp":1770822195723,"version":"3.50.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1097\/cco.0b013e32833d7dbe","type":"journal-article","created":{"date-parts":[[2010,7,30]],"date-time":"2010-07-30T09:52:49Z","timestamp":1280483569000},"page":"443-448","source":"Crossref","is-referenced-by-count":17,"title":["Controversies in the treatment of Burkitt lymphoma in AIDS"],"prefix":"10.1097","volume":"22","author":[{"given":"Ariela","family":"Noy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210128","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/ajcp\/103.5.561","article-title":"AIDS-related Burkitt's lymphoma. Morphologic and immunophenotypic study of biopsy specimens","volume":"103","author":"Carbone","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"R2-8-20210128","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0025-7125(16)30379-0","article-title":"AIDS-associated malignant lymphoma","volume":"76","author":"Levine","year":"1992","journal-title":"Med Clin North Am"},{"key":"R3-8-20210128","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0140-6736(91)92513-2","article-title":"AIDS-associated non-Hodgkin lymphoma","volume":"337","author":"Beral","year":"1991","journal-title":"Lancet"},{"key":"R4-8-20210128","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/CCO.0b013e32832f3dcd","article-title":"Lessons from clinical trials in African Burkitt lymphoma","volume":"21","author":"Magrath","year":"2009","journal-title":"Curr Opin Oncol"},{"key":"R6-8-20210128","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1182\/blood-2004-02-0405","article-title":"Adult Burkitt leukemia and lymphoma","volume":"104","author":"Blum","year":"2004","journal-title":"Blood"},{"key":"R7-8-20210128","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1182\/blood.V87.2.495.bloodjournal872495","article-title":"Improved outcome in adult B-cell acute lymphoblastic leukemia","volume":"87","author":"Hoelzer","year":"1996","journal-title":"Blood"},{"key":"R8-8-20210128","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.1996.14.3.925","article-title":"Adults and children with small noncleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen","volume":"14","author":"Magrath","year":"1996","journal-title":"J Clin Oncol"},{"key":"R9-8-20210128","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood.V97.11.3370","article-title":"The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia","volume":"97","author":"Patte","year":"2001","journal-title":"Blood"},{"key":"R10-8-20210128","first-page":"3294","article-title":"Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90","volume":"94","author":"Reiter","year":"1999","journal-title":"Blood"},{"key":"R11-8-20210128","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199706053362304","article-title":"Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group","volume":"336","author":"Kaplan","year":"1997","journal-title":"N Engl J Med"},{"key":"R12-8-20210128","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/cncr.11628","article-title":"Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate\/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M\/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma","volume":"98","author":"Wang","year":"2003","journal-title":"Cancer"},{"key":"R13-8-20210128","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/cncr.20019","article-title":"Intensive sequential chemotherapy with hematopoietic growth factor support for non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus","volume":"100","author":"Costello","year":"2004","journal-title":"Cancer"},{"key":"R14-8-20210128","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/cncr.10365","article-title":"Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma\/leukemia","volume":"94","author":"Cortes","year":"2002","journal-title":"Cancer"},{"key":"R15-8-20210128","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/1042819031000141301","article-title":"Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity","volume":"45","author":"Lacasce","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"R17-8-20210128","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1182\/blood-2008-03-145128","article-title":"A prospective clinicopathologic study of dose-modified CODOX-M\/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC\/NCRI LY10 trial)","volume":"112","author":"Mead","year":"2008","journal-title":"Blood"},{"key":"R18-8-20210128","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1182\/blood-2002-11-3589","article-title":"Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology","volume":"101","author":"Little","year":"2003","journal-title":"Blood"},{"key":"R20-8-20210128","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood-2005-04-1437","article-title":"Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010","volume":"106","author":"Kaplan","year":"2005","journal-title":"Blood"},{"key":"R21-8-20210128","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1182\/blood-2009-08-231613","article-title":"Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma","volume":"115","author":"Sparano","year":"2010","journal-title":"Blood"},{"key":"R22-8-20210128","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1182\/blood-2009-11-253039","article-title":"The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma","volume":"115","author":"Dunleavy","year":"2010","journal-title":"Blood"},{"key":"R24-8-20210128","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/ijc.24934","article-title":"Trimodal age-specific incidence patterns for Burkitt lymphoma in the United States, 1973-2005.","volume":"126","author":"Mbulaiteye","year":"2010","journal-title":"Int J Cancer"},{"key":"R25-8-20210128","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/QAI.0b013e3181b563e7","article-title":"Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States","volume":"53","author":"Harrison","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R26-8-20210128","first-page":"564","article-title":"Morbidity and mortality in HIV-infected individuals: a shift towards comorbidities","volume":"139","author":"Battegay","year":"2009","journal-title":"Swiss Med Wkly"},{"key":"R27-8-20210128","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3816\/CLM.2009.n.060","article-title":"Outcomes of patients with Burkitt lymphoma older than age 40 treated with intensive chemotherapeutic regimens","volume":"9","author":"Kelly","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"R28-8-20210128","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/leu.2008.304","article-title":"Early events of B-cell receptor signaling are not essential for the proliferation and viability of AIDS-related lymphoma","volume":"23","author":"Lu","year":"2009","journal-title":"Leukemia"},{"key":"R29-8-20210128","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/leu.2008.163","article-title":"Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib","volume":"22","author":"Yang","year":"2008","journal-title":"Leukemia"},{"key":"R30-8-20210128","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2141.2003.04644.x","article-title":"Frequent aberrant promoter hypermethylation of O6-methylguanine-DNA methyltransferase and death-associated protein kinase genes in immunodeficiency-related lymphomas","volume":"123","author":"Rossi","year":"2003","journal-title":"Br J Haematol"},{"key":"R31-8-20210128","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2141.2009.07943.x","article-title":"Genome wide DNA-profiling of HIV-related B-cell lymphomas.","volume":"148","author":"Capello","year":"2010","journal-title":"Br J Haematol"}],"container-title":["Current Opinion in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCO.0b013e32833d7dbe","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T16:27:11Z","timestamp":1740328031000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001622-201009000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/cco.0b013e32833d7dbe","relation":{},"ISSN":["1040-8746"],"issn-type":[{"value":"1040-8746","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}